The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?
The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simp...
Gespeichert in:
Veröffentlicht in: | Oncology letters 2010-01, Vol.1 (1), p.187-188 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 188 |
---|---|
container_issue | 1 |
container_start_page | 187 |
container_title | Oncology letters |
container_volume | 1 |
creator | LIM, S.Y HORSMAN, J.M HANCOCK, B.W |
description | The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice. |
doi_str_mv | 10.3892/ol_00000034 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3436357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859678169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhi1UBBFw4l75hCqhBX9sbG8Praq0QKSg9pBeuFjOejZx2bUX26Hl37M0EGA00oz0PnpnNIPQMSVnXFXsPLSa_A9e7qARlRUrKFHsw7aX5T46SunPEzMWVCmxh_YZq4RgiozQzXwF-Nr43AKeQNvi2UPXr0Jn8NRniN5kF7xp8a8Ylj6k7OpBsPDvM_4eIGGX8d8Qb7HzOIZ1dh5wH009YPD1EO02pk1w9FwP0O-LH_PJVTH7eTmdfJsVdUlZLpiUfNFw0gA0isoSFGdWCsoIY9aKUjGlDC8Nrw0MirUSFlAzIgiMmRKMH6AvG99-vejA1uBzNK3uo-tMfNDBOP1e8W6ll-Fe85ILPpaDwadngxju1pCy7lyqh2MYD2GdNFXjSkhFRTWgpxu0jiGlCM12DCX66SH6zUMG-uPbzbbsy_kH4GQDpN5462xIr2u3BaGbVJI_Ajl2k10</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859678169</pqid></control><display><type>article</type><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><source>Spandidos Publications Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</creator><creatorcontrib>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</creatorcontrib><description>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol_00000034</identifier><identifier>PMID: 22966280</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Mantle Cell Lymphoma International Prognostic Index</subject><ispartof>Oncology letters, 2010-01, Vol.1 (1), p.187-188</ispartof><rights>Copyright © 2010, Spandidos Publications</rights><rights>Copyright © 2010, Spandidos Publications 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</citedby><cites>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436357/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436357/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,5556,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22966280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIM, S.Y</creatorcontrib><creatorcontrib>HORSMAN, J.M</creatorcontrib><creatorcontrib>HANCOCK, B.W</creatorcontrib><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><title>Oncology letters</title><addtitle>Oncol Lett</addtitle><description>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</description><subject>Mantle Cell Lymphoma International Prognostic Index</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkU1PGzEQhi1UBBFw4l75hCqhBX9sbG8Praq0QKSg9pBeuFjOejZx2bUX26Hl37M0EGA00oz0PnpnNIPQMSVnXFXsPLSa_A9e7qARlRUrKFHsw7aX5T46SunPEzMWVCmxh_YZq4RgiozQzXwF-Nr43AKeQNvi2UPXr0Jn8NRniN5kF7xp8a8Ylj6k7OpBsPDvM_4eIGGX8d8Qb7HzOIZ1dh5wH009YPD1EO02pk1w9FwP0O-LH_PJVTH7eTmdfJsVdUlZLpiUfNFw0gA0isoSFGdWCsoIY9aKUjGlDC8Nrw0MirUSFlAzIgiMmRKMH6AvG99-vejA1uBzNK3uo-tMfNDBOP1e8W6ll-Fe85ILPpaDwadngxju1pCy7lyqh2MYD2GdNFXjSkhFRTWgpxu0jiGlCM12DCX66SH6zUMG-uPbzbbsy_kH4GQDpN5462xIr2u3BaGbVJI_Ajl2k10</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>LIM, S.Y</creator><creator>HORSMAN, J.M</creator><creator>HANCOCK, B.W</creator><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201001</creationdate><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><author>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Mantle Cell Lymphoma International Prognostic Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LIM, S.Y</creatorcontrib><creatorcontrib>HORSMAN, J.M</creatorcontrib><creatorcontrib>HANCOCK, B.W</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIM, S.Y</au><au>HORSMAN, J.M</au><au>HANCOCK, B.W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</atitle><jtitle>Oncology letters</jtitle><addtitle>Oncol Lett</addtitle><date>2010-01</date><risdate>2010</risdate><volume>1</volume><issue>1</issue><spage>187</spage><epage>188</epage><pages>187-188</pages><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>22966280</pmid><doi>10.3892/ol_00000034</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-1074 |
ispartof | Oncology letters, 2010-01, Vol.1 (1), p.187-188 |
issn | 1792-1074 1792-1082 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3436357 |
source | Spandidos Publications Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Mantle Cell Lymphoma International Prognostic Index |
title | The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A18%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Mantle%20Cell%20Lymphoma%20International%20Prognostic%20Index:%20Does%20it%20work%20in%20routine%20practice?&rft.jtitle=Oncology%20letters&rft.au=LIM,%20S.Y&rft.date=2010-01&rft.volume=1&rft.issue=1&rft.spage=187&rft.epage=188&rft.pages=187-188&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol_00000034&rft_dat=%3Cproquest_pubme%3E1859678169%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1859678169&rft_id=info:pmid/22966280&rfr_iscdi=true |